HP and irritable bowel syndrome: Elevated serum zonulin levels, a marker of increased intestinal permeability, have been consistently observed in IBS patients (Linsalata et al., 2018; Seethaler et al., 2021) and, to a lesser extent, in FM populations (Erdrich et al., 2020a).